Industry News

Biotech

• Palladio grabs $20M to take once-discarded drug through phase 3 2020/09/25
  Palladio grabs $20M to take once-discarded drug through phase 3 ntaylor Fri, 09/25/2020 – 08:06
• New atlas of the human heart could guide personalized medicine in cardiology 2020/09/25
  New atlas of the human heart could guide personalized medicine in cardiology arlene.weintraub Fri, 09/25/2020 – 07:56
• Novavax kick-starts phase 3 of COVID-19 vaccine in U.K. as cases surge across the country 2020/09/25
  Novavax kick-starts phase 3 of COVID-19 vaccine in U.K. as cases surge across the country badams Fri, 09/25/2020 – 07:04
• Flagship's Valo emerges with $100M and plans to transform R&D 2020/09/25
  Flagship's Valo emerges with $100M and plans to transform R&D ntaylor Fri, 09/25/2020 – 05:59
• Looking for an edge in the wet AMD market, phase 3 biotech Opthea guns for $150M IPO 2020/09/25
  Looking for an edge in the wet AMD market, phase 3 biotech Opthea guns for $150M IPO badams Fri, 09/25/2020 – 03:53

Medical Devices

Error: Feed has an error or is not valid

Pharma

• Bristol Myers Squibb's Opdivo cuts relapse risk in muscle-invasive bladder cancer 2020/09/25
  Bristol Myers Squibb's Opdivo cuts relapse risk in muscle-invasive bladder cancer chelfand Fri, 09/25/2020 – 12:18
• Gilead's rheumatoid arthritis med filgotinib, after cold shoulder from FDA, wins global-first nod in Japan 2020/09/25
  Gilead's rheumatoid arthritis med filgotinib, after cold shoulder from FDA, wins global-first nod in Japan aliu Fri, 09/25/2020 – 10:54
• Merck, advancing single-dose and oral coronavirus vaccines, could still make Warp Speed: Bloomberg 2020/09/25
  Merck, advancing single-dose and oral coronavirus vaccines, could still make Warp Speed: Bloomberg esagonowsky Fri, 09/25/2020 – 09:49
• As phase 3 kicks off, Novavax and Endo ink manufacturing pact for COVID-19 vaccine 2020/09/25
  As phase 3 kicks off, Novavax and Endo ink manufacturing pact for COVID-19 vaccine kblankenship Fri, 09/25/2020 – 09:09
• FiercePharmaAsia—Legend CEO probe; AZ-Samsung biologics deal; Fujifilm's Avigan in COVID-19 2020/09/25
  FiercePharmaAsia—Legend CEO probe; AZ-Samsung biologics deal; Fujifilm's Avigan in COVID-19 aliu Fri, 09/25/2020 – 06:00

Vaccines

Error: Feed has an error or is not valid